Mechanisms of HIV persistence in the kidney

HIV 在肾脏中持续存在的机制

• 批准号: 10672297
• 负责人: Maria Blasi
• 金额: $ 66.26万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-01 至 2027-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10672297
• 关键词: AIDS-Associated Nephropathy; APOL1 gene; Affect; Aftercare; Anti-Retroviral Agents; Archives; Automobile Driving; Autopsy; Base Sequence; Biopsy Specimen; Blood; CD4 Positive T Lymphocytes; Cell Death; Cell Proliferation; Cells; Chronic Disease; Clonal Expansion; Coculture Techniques; Consent; Data; Detection; Development; Epithelial Cells; Frequencies; Gene Expression; Gene Expression Profile; Genes; Genetic; Genetic Recombination; Genitourinary system; Genomic DNA; Growth; HIV; HIV Infections; HIV Seropositivity; HIV-1; Hypertrophy; Immune; In Vitro; Individual; Infection; Infiltration; Interruption; Kidney; Kidney Diseases; Kidney Transplantation; Location; Macrophage; Morbidity - disease rate; Pathogenesis; Pathology; Pathway interactions; Patients; Peripheral Blood Mononuclear Cell; Persons; Pharmaceutical Preparations; Phenotype; Phylogenetic Analysis; Plasma; Proliferating; Property; Protocols documentation; Renal tubule structure; Reporting; Research; Role; Sampling; Sequence Analysis; Site; Source; Specimen; System; T-Lymphocyte; Terminal Disease; Terminally Ill; Time; Tissues; Transplantation; Urine; Viral; Viral Load result; Viral Pathogenesis; Viral reservoir; Virus; Virus Latency; Virus Shedding; Work; antiretroviral therapy; chronic infection; experience; fighting; follow-up; improved; in vivo; induced pluripotent stem cell; integration site; kidney allograft; kidney biopsy; kidney cell; kidney infection; longitudinal analysis; mortality; organ injury; podocyte; prospective; renal epithelium; risk variant; single-cell RNA sequencing; urogenital tract; viral RNA; viral detection; viral rebound

ABSTRACT Despite the dramatic improvement in HIV-associated morbidity and mortality with combination antiretroviral therapy (ART), HIV remains a chronic disease. The major barrier to HIV cure is the long-term persistence of multiple, latent viral reservoirs capable of reactivation in the absence of ART. Any effort to eradicate these reservoirs as part of a cure initiative requires understanding of the dynamics and control of HIV reactivation and replication in tissues and cells harboring the virus long-term. Our work has focused on understanding the mechanisms and implications of HIV infection of the kidney. We demonstrated that HIV infects renal tubule epithelial cells (RTEs) in vitro via direct contact with HIV-infected T cells and macrophages. Viral nucleic acid sequence analysis from in vivo derived RTEs compared to blood derived sequences demonstrated that the kidney represents a unique viral compartment. Furthermore, we showed that people with HIV (PWH) shed viral RNA in urine, and we have optimized approaches to detect and amplify HIV sequences from fresh and archived urine specimens. We found that some urine-derived HIV sequences were closely related to HIV sequences amplified from RTEs, supporting those cells as one of the sources of urine viruses. Viral detection in the urine allows for repeated sampling of the kidney compartment, which can be particularly useful in viral rebound studies. Additionally, in all of the PLWH we have analyzed so far, we amplified several identical HIV-1 sequences in urine, raising the possibility of clonal expansion of infected renal cells. Indeed, we recently reported that proliferation is one of the cellular fates observed in both actively and latently infected RTEs in vitro, together with hypertrophy and cell-death. Whether proliferation of infected renal epithelial cells contributes to HIV persistence in the kidney is unknown. The studies proposed here will define: 1) the long-term persistence of HIV in the kidney through the analysis of samples collected prospectively from PWH undergoing HIV+ to HIV+ kidney transplantation; 2) the reactivation potential of HIV in urine following ART interruption in terminally ill PWH who have consented to prospective follow-up as part of a rapid autopsy protocol; 3) the ability of patient-derived renal epithelial cells to carry replication competent virus; 4) the role of APOL1 kidney disease risk variants in RTE and podocyte infection; and 5) how HIV infection influences individual cell fate and potential for clonal expansion of infected RTEs. We hypothesize that renal epithelial cells serve as a long-term reservoir for HIV. Understanding the mechanisms of HIV persistence and reactivation in the kidney will inform cure strategies and further define renal pathogenesis in PLWH.

摘要 尽管联合抗逆转录病毒药物显著改善了艾滋病毒相关的发病率和死亡率 艾滋病病毒仍然是一种慢性病。艾滋病毒治愈的主要障碍是长期持续的 在没有抗逆转录病毒治疗的情况下，多个潜伏的病毒库能够重新激活。任何根除这些病毒的努力 作为治愈计划的一部分，水库需要了解艾滋病毒重新激活的动态和控制 以及在长期携带病毒的组织和细胞中进行复制。 我们的工作重点是了解HIV感染肾脏的机制和影响。我们 证明HIV通过与HIV感染的T细胞直接接触在体外感染肾小管上皮细胞(RTES) 细胞和巨噬细胞。体内rTES病毒核酸序列与血液的比较分析 衍生的序列表明，肾脏代表着一个独特的病毒隔间。此外，我们 显示艾滋病毒携带者(PWH)从尿液中排出病毒RNA，我们已经优化了检测和 从新鲜和存档的尿样中扩增HIV序列。我们发现一些尿液衍生的艾滋病毒 序列与从RTES扩增的HIV序列密切相关，支持这些细胞作为 尿液病毒的来源。尿液中的病毒检测允许对肾脏隔室进行重复采样， 这在病毒反弹研究中特别有用。此外，在我们分析的所有PLWH中， 到目前为止，我们在尿液中扩增了几个相同的HIV-1序列，增加了克隆扩增的可能性 被感染的肾细胞。事实上，我们最近报告说，增殖是观察到的两者的细胞命运之一。 体外主动和潜伏感染rtes，并伴有肥大和细胞死亡。是否存在扩散 被感染的肾上皮细胞对HIV在肾脏中持续存在的贡献尚不清楚。 这里提出的研究将定义：1)通过分析艾滋病毒在肾脏中的长期持久性 从威尔斯亲王进行HIV+到HIV+肾移植的预期样本；2)重新激活 同意接受抗逆转录病毒治疗的绝症重症威斯康星患者终止抗逆转录病毒治疗后尿中艾滋病毒的可能性 作为快速尸检程序的一部分的随访；3)患者来源的肾上皮细胞携带 复制能力强的病毒；4)APOL1肾病危险变异体在RTE和足细胞感染中的作用； 5)HIV感染如何影响单个细胞的命运和受感染的RTE的克隆性扩张。我们 假设肾上皮细胞是HIV的长期储存库。了解以下机制： HIV在肾脏中的持续和重新激活将为治疗策略提供信息，并进一步确定肾脏的发病机制 在PLWH。